Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Today: 27/07/2026 · FUTURE · Forthcoming · Viewed
Funding agency: Horizon Europe
Call: HORIZON-HLTH-2027-01
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions | Deadline model: single-stage | Planned opening: 10/02/2027 | Model Grant Agreement: HORIZON Action Grant Budget-Based
The call aims to support research and innovation actions in the area of personalised healthcare, focusing on reducing risks from adverse drug reactions due to administration of multiple medications.
Budget total: 9000000.0 EUR | Budget per project: — EUR
Deadline: 13/04/2027 (260 days left) | Duration: — months | Funding intensity: —% | Type: research and innovation actions
Eligibility: entity types: legal entity; countries: EU countries
#healthcare#personalised medicine#adverse drug reactions
Health
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| European Centre for Emerging Competencies and Technologies | 65% | ollama |
The organization's expertise in emerging competencies, digital transformation, a…The organization's expertise in emerging competencies, digital transformation, and environmental sustainability is partially aligned with the opportunity's focus on personalized healthcare and reducing adverse drug reactions. The tags 'AgriTech Solutions' and 'Digital solutions' from the profile's domains/technologies match the broader domain of 'Health', but there are no specific overlaps in technologies (e.g. AI and Big Data) that are typically applied in this area. |
Override |
| Novatex Solutions LTD | 0% | ollama |
No direct overlap in domains/technologies between Novatex Solutions LTD and the …No direct overlap in domains/technologies between Novatex Solutions LTD and the opportunity 'Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications' (Health domain does not align with Novatex's broader sector of Manufacturing / Robotics). The company's profile emphasizes ICT, AI, robotics, and IoT projects, which do not match this health-focused opportunity. [Weighted score: 0% AI judgment (65%) + 0% domain/technology tag overlap (35%) = 0%] |
Override |